A new publication involving humanin appeared on August 24, 2026, in the journal Alpha Psychiatry. The paper is titled "Low Dose Ketamine Preconditions Astrocyte Mitochondria to Achieve Antidepressant Efficacy via Adenosine, Humanin, and Melatonin Upregulation and Efflux."
The publication is indexed under PubMed ID 42694894. Humanin remains classified as an unapproved compound used only in research settings. This entry reflects the existence and title of the publication as recorded, without summarizing specific findings, mechanisms, or conclusions beyond what is stated in the title itself.
Readers interested in the broader context of humanin research, including its regulatory status and general background, can consult the compound overview for additional information.